Session 1: Year in Review - HCC and Liver Metastatic Disease

HCC: Year in Review
Nora Tabori, MD, Chief of Interventional Radiology, MedStar Washington Hospital Center

Medical Therapies for HCC: An Oncologist's Algorithm
Fernando I. De Zarraga, Jr., MD, Medical Oncology, Miami Cancer Institute

HCC Panel: What Else Happened
Michael Chuong, MD, Edward Kim, MD, Nadine Abi-Jaoudeh, MD, Karen T. Brown, MD, FSIR, Nima Kokabi, MD

Liver Metastatic Disease: Year in Review
Ahmed K. Abdel Aal, MD, PhD, Professor and Director of Interventional Radiology, Vice Chair of Faculty Affairs, University of Texas Health Science Center at Houston

Liver Metastatic Disease Panel: What Else Happened
Horacio Asbun, MD, FACS, Constantinos T. Sofocleous, MD, PhD, Sarah Nadia Joseph, MD

The Evolving Role of Hepatic Ablation
Raul N. Uppot, MD, Interventional Radiologist, Massachusetts General Hospital

Contemporary Utilization of Liver Radiation: A Radiation Oncologist's Perspective
Michael Chuong, MD, Radiation Oncologist, Miami Cancer Institute

A Surgeon's Perspective on Locoregional Therapies
Horacio Asbun, MD, FACS, Chief of Hepatobiliary and Pancreatic Surgery, Miami Cancer Institute

Practical Approach to Liver Disease: Multidisciplinary Tumor Board
Edward Kim, MD, Horacio Asbun, MD, FACS, Michael Chuong, MD, Raul N. Uppot, MD, Fernando I. De Zarraga, Jr., MD, Nora Tabori, MD, Santiago Aparo, MD, MS, Karen T. Brown, MD, FSIR, Nadine Abi-Jaoudeh, MD